PL343677A1 - Paroxetine ascorbate - Google Patents

Paroxetine ascorbate

Info

Publication number
PL343677A1
PL343677A1 PL99343677A PL34367799A PL343677A1 PL 343677 A1 PL343677 A1 PL 343677A1 PL 99343677 A PL99343677 A PL 99343677A PL 34367799 A PL34367799 A PL 34367799A PL 343677 A1 PL343677 A1 PL 343677A1
Authority
PL
Poland
Prior art keywords
paroxetine ascorbate
paroxetine
ascorbate
Prior art date
Application number
PL99343677A
Other languages
English (en)
Inventor
Michael Urquhart
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PL343677A1 publication Critical patent/PL343677A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL99343677A 1998-04-25 1999-04-23 Paroxetine ascorbate PL343677A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808896.6A GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound

Publications (1)

Publication Number Publication Date
PL343677A1 true PL343677A1 (en) 2001-08-27

Family

ID=10831008

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99343677A PL343677A1 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate

Country Status (20)

Country Link
EP (1) EP1089995A1 (no)
JP (1) JP2002513019A (no)
KR (1) KR20010042977A (no)
CN (1) CN1297448A (no)
AP (1) AP2000001963A0 (no)
AU (1) AU3618499A (no)
BG (1) BG104940A (no)
BR (1) BR9909868A (no)
CA (1) CA2330055A1 (no)
EA (1) EA200001104A1 (no)
GB (1) GB9808896D0 (no)
HU (1) HUP0102116A3 (no)
ID (2) ID26083A (no)
IL (1) IL139081A0 (no)
NO (1) NO20005352L (no)
PL (1) PL343677A1 (no)
SK (1) SK15912000A3 (no)
TR (1) TR200003084T2 (no)
WO (1) WO1999055698A1 (no)
ZA (1) ZA200005912B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
WO2003057650A2 (en) 2002-01-09 2003-07-17 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
CN110607553B (zh) * 2018-10-30 2024-03-22 中国科学院化学研究所 一种制备粒径可调的药物或药物中间体单晶或无定型物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.

Also Published As

Publication number Publication date
TR200003084T2 (tr) 2001-02-21
SK15912000A3 (sk) 2001-04-09
ID26083A (id) 2000-11-23
EA200001104A1 (ru) 2001-04-23
ZA200005912B (en) 2001-12-19
CN1297448A (zh) 2001-05-30
AP2000001963A0 (en) 2000-12-31
NO20005352D0 (no) 2000-10-24
IL139081A0 (en) 2001-11-25
KR20010042977A (ko) 2001-05-25
ID26654A (id) 2001-01-25
GB9808896D0 (en) 1998-06-24
EP1089995A1 (en) 2001-04-11
HUP0102116A2 (hu) 2002-05-29
WO1999055698A1 (en) 1999-11-04
AU3618499A (en) 1999-11-16
BG104940A (bg) 2001-09-28
NO20005352L (no) 2000-10-24
BR9909868A (pt) 2000-12-19
CA2330055A1 (en) 1999-11-04
HUP0102116A3 (en) 2002-12-28
JP2002513019A (ja) 2002-05-08

Similar Documents

Publication Publication Date Title
GB2342193B (en) Addition circuitry
GB0000446D0 (en) Early entry
GB2336364B (en) Paroxetine salt
IL141226A0 (en) 1h-imidazopyridine derivatives
GB0030695D0 (en) Early case
GB0015176D0 (en) Early entry
GB0016917D0 (en) Early entry
PL345540A1 (en) Thiobenzimidazole derivatives
HU9900120D0 (en) Benzosulfone derivatives
GB9809664D0 (en) a-Ketoamide derivatives
GB0010544D0 (en) Early entry
GB0004234D0 (en) Early entry
ZA992191B (en) Piperidine derivatives.
EG23802A (en) 2-Phenylpyran-4-one derivatives
ZA200101830B (en) Piperidine derivatives.
GB9909183D0 (en) Early entry
PL343378A1 (en) Paroxetine maleate
GB9902662D0 (en) Early entry
GB9827729D0 (en) Thieno-indole derivatives
IL138478A0 (en) Paroxetine compositions
IL139081A0 (en) Paroxetine ascorbate
EP1061912A4 (en) PHENANTHROFURANDERIVATE
HUP0101215A3 (en) Chrystalline form of paroxetine
GB9801096D0 (en) Access means
IL139276A0 (en) Cyclohexenondioxthio chromanoyl derivatives

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)